V030-6420 Screening compound: N-(1-{[5-(2H-1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)decanamide

V030-6420 Screening compound: N-(1-{[5-(2H-1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)decanamide
V030-6420 Screening compound: N-(1-{[5-(2H-1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)decanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-6420
N-(1-{[5-(2H-1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)decanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-6420

Molecular Formula

C28H34N4O4S (C28 H34 N4 O4 S)

Compound Name

N-(1-{[5-(2H-1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)decanamide

IUPAC name

N-(1-{[5-(2H-13-benzodioxol-5-yl)-134-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)decanamide

SMILES

CCCCCCCCCC(NC(Cc1ccccc1)C(Nc1nnc(-c(cc2)cc3c2OCO3)s1)=O)=O

InChI

InChI=1S/C28H34N4O4S/c1-2-3-4-5-6-7-11-14-25(33)29-22(17-20-12-9-8-10-13-20)26(34)30-28-32-31-27(37-28)21-15-16-23-24(18-21)36-19-35-23/h8-10,12-13,15-16,18,22H,2-7,11,14,17,19H2,1H3,(H,29,33)(H,30,32,34)/t22-/m0/s1

InChI Key

PZRNNQHXIYSUTB-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD19723325

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

522.67

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

16.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

7.080

Distribution Coefficient, logD

7.079

Water Solubility, LogSw

-5.62

Polar Surface Area

87.820

Acid Dissociation Constant (pKa)

10.06

Base Dissociation Constant (pKb)

-2.73

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.90

V030-6420 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V030-6420 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-6420?
Check Price and Availability of V030-6420, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-6420 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-6420
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-6420
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-6420 available by request